Short interest in Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) decreased during the last reporting period, falling from 173.85K to 148.23K. This put 2.74% of the company's publicly available shares short.

Short interest for Brainstorm Cell gives investors a sense of the degree to which investors are betting on the decline of Brainstorm Cell's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 99.45K shares traded per day, it would take 1.49 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.